miRNA 测序和检测市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

miRNA 测序和检测市场按产品(测序耗材和文库制备试剂盒)、技术、最终用户和地理位置细分

市场快照

mirna-sequencing-and-assay-market_Market Summary
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 10.9 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

导致增长的重要因素是传染病流行率的上升,新技术的发展和评估 miRNA 序列的不同技术的引入将在预测市场期间推动 miRNA 测序和分析市场的市场增长。在诊断和预后行业,miRNA 测序方法有能力成为必不可少的工具。具有成本效益的测序方法日益普及、癌症发病率上升以及基因组学研究活动的增加也将推动未来几年对 miRNA 测序和分析的市场需求。

报告范围

miRNA测序是RNA-seq的一种,它使用下一代测序或高通量DNA的大规模并行测序来对microRNA进行模式化。在解码 miRNA 的方法中使用的物质;这种测序与 RNA 测序有点不同。

By Product
Sequencing Consumables
Library Preparation Kits
By Technology
Sequencing by Synthesis
Ion Semiconductor
SOLiD
Nanopore Sequencing
By End User
Clinical Laboratory
Life Science Organization
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

文库制备试剂盒有望在 miRNA 测序和检测市场占据最大市场份额

由于基因组相关研究和癌症研究的增加以及对下一代测序技术的高需求,文库制备试剂盒部分保留了主导份额,因为它有能力提供潜在的医疗保健解决方案。

该细分市场的增长也可归因于癌症和传染病等慢性病的高发病率。根据世界卫生组织的估计,不断上升的慢性病是一项全球性挑战,占全球所有死亡人数的 60% 以上。根据 GLOBOCAN 2018 的统计数据,全球有 2,088,849 人患有乳腺癌。亚洲仍然是乳腺癌发病率上升的贡献者,报告的份额为 43.6%,其次是欧洲、北美和拉丁美洲、非洲和大洋洲,分别为 25%、12.6% 和 9.6%、8.1% 和 1.2%分别。

Common Cancer Cases.png

北美在市场上占主导地位,预计在预测期内也会如此

由于越来越多地采用先进技术,该地区正在获得很高的市场份额。这是由于诸如开展研究和开发活动的举措不断增加等因素是该市场在该地区增长的关键因素。越来越多的传染病是市场增长的关键驱动力。然而,需求是由癌症发病率上升推动的。诸如致力于基因组研究的世界级学者和研究设施的可用性增加了政府对基因研究的资助,以及对 miRNA 研究的技术、高通量技术的需求增加,这些因素是在全球范围内提高区域份额的其他因素。预测期。

miRNA Sequencing and Assay Market 2

竞争格局

miRNA 测序和检测市场竞争适度,由少数主要参与者组成。就市场份额而言,目前很少有主要参与者占据市场主导地位。一些知名企业正在大力收购其他公司并推出新产品,以巩固其在全球的市场地位。目前主导市场的一些公司是 Illumina, Inc.、Thermo Fisher Scientific、Qiagen NV、Perkinelmer, Inc. 和 Takara Bio, Inc.。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 MiRNA Sequencing and Assay Sequencing supremacy over other methods

      2. 4.2.2 Increased research in the field of genomics drive the miRNA sequencing adoption

      3. 4.2.3 Reduced sequencing costs

    3. 4.3 Market Restraints

      1. 4.3.1 Paucity of expert and need for computing infrastructure

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Sequencing Consumables

      2. 5.1.2 Library Preparation Kits

    2. 5.2 By Technology

      1. 5.2.1 Sequencing by Synthesis

      2. 5.2.2 Ion Semiconductor

      3. 5.2.3 SOLiD

      4. 5.2.4 Nanopore Sequencing

    3. 5.3 By End User

      1. 5.3.1 Clinical Laboratory

      2. 5.3.2 Life Science Organization

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Illumina, Inc.

      2. 6.1.2 Thermo Fisher Scientific

      3. 6.1.3 Qiagen N.V.

      4. 6.1.4 PerkinElmer, Inc.

      5. 6.1.5 Takara Bio, Inc.

      6. 6.1.6 New England Biolabs, Inc.

      7. 6.1.7 Norgen Biotek Corporation

      8. 6.1.8 Trilink Biotechnologies

      9. 6.1.9 Lexogen

      10. 6.1.10 Oxford Nanopore Technologies

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The miRNA Sequencing and Assay Market market is studied from 2018 - 2026.

The miRNA Sequencing and Assay Market is growing at a CAGR of 10.9% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Illumina, Inc., Thermo Fisher Scientific, Qiagen N.V., Perkinelmer, Inc., Takara Bio, Inc. are the major companies operating in miRNA Sequencing and Assay Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!